| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | - | - | - | 0 | 17.200 | 32.198 | 81.368 |
| Total Income - EUR | 0 | 0 | 0 | - | - | - | 0 | 19.228 | 32.198 | 81.550 |
| Total Expenses - EUR | 3.960 | 7.510 | 0 | - | - | - | 10.141 | 43.925 | 52.133 | 59.660 |
| Gross Profit/Loss - EUR | -3.960 | -7.510 | 0 | - | - | - | -10.141 | -24.698 | -19.934 | 21.890 |
| Net Profit/Loss - EUR | -3.960 | -7.510 | 0 | - | - | - | -10.141 | -24.870 | -20.009 | 18.378 |
| Employees | 0 | 0 | 0 | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sara Laboratory Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 85.083 | 84.215 | 82.790 | - | - | - | 81.352 | 82.693 | 81.827 | 80.758 |
| Current Assets | 939 | 923 | 908 | - | - | - | 6.571 | 4.930 | 2.681 | 246 |
| Inventories | 0 | 0 | 0 | - | - | - | 585 | 1.773 | 1.767 | 0 |
| Receivables | 910 | 901 | 886 | - | - | - | 2.955 | 1.666 | 231 | 32 |
| Cash | 28 | 22 | 22 | - | - | - | 3.031 | 1.491 | 683 | 214 |
| Shareholders Funds | -1.919 | -9.409 | -9.250 | - | - | - | -18.683 | -43.611 | -63.488 | -44.755 |
| Social Capital | 225 | 223 | 219 | - | - | - | 202 | 203 | 202 | 201 |
| Debts | 87.940 | 94.548 | 92.948 | - | - | - | 106.607 | 131.234 | 147.996 | 125.759 |
| Income in Advance | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Sara Laboratory Srl